MAPT and Alzheimer disease: The level of tau hyperphosphorylation in our study is in line with the tau hyperphosphorylation demonstrated by Cohen and colleagues in the same TgF344-AD rat model38 (and followed by NFT formation at 16 months of age38) and in human AD brain50, 51, 67.